Clinical Trials

Showing trials with last updates posted in 2026.

NCT06298084 | RECRUITING | PHASE1/PHASE2
152 participants

Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2024-03-21
Completion:
2027-09-30
Conditions
  • Breast Cancer Metastatic
  • HER2-positive Metastatic Breast Cancer
  • HER2 Low Breast Carcinoma
  • Advanced Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT06236438 | RECRUITING | PHASE2/PHASE3
840 participants
NCT06226181 | COMPLETED | NA
22 participants

Amniotic Membrane for Dacryocystorhinostomy

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2024-01-01
Completion:
2025-02-01
Conditions
  • Nasolacrimal Duct Obstruction
  • Dacryocystorhinostomy
Interventions
  • PROCEDURE
No Results Yet
NCT06203600 | RECRUITING | PHASE2/PHASE3
224 participants

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2024-06-24
Completion:
2027-10-31
Conditions
  • Advanced Esophageal Adenocarcinoma
  • Advanced Gastric Adenocarcinoma
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Unresectable Esophageal Adenocarcinoma
  • Unresectable Gastric Adenocarcinoma
  • Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT06167486 | COMPLETED | PHASE1
17 participants

SG2918 For Advanced Malignant Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2023-12-26
Completion:
2025-11-11
Conditions
  • Advanced Malignant Tumors
Interventions
  • DRUG
No Results Yet
NCT06126276 | RECRUITING | PHASE2
70 participants

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2024-05-07
Completion:
2027-02-20
Conditions
  • Malignant Female Reproductive System Neoplasm
  • Malignant Solid Neoplasm
  • Recurrent Malignant Female Reproductive System Neoplasm
  • Recurrent Malignant Solid Neoplasm
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT06124157 | RECRUITING | PHASE2
222 participants

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-05-30
Completion:
2030-12-01
Conditions
  • B Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • RADIATION
No Results Yet
NCT06112860 | RECRUITING | NA
50 participants

OTC Hearing Aid and MCI

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2024-07-23
Completion:
2026-12-31
Conditions
  • Hearing Loss
  • Mild Cognitive Impairment
  • Alzheimer Disease and Related Dementias (ADRD)
Interventions
  • DEVICE
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page